STCOSD
MYGN icon

Sageworth Trust Company of South Dakota’s Myriad Genetics MYGN Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41
Closed -$1K – 493
2022
Q2 		$1K Hold
41
– – ﹤0.01% 502
2022
Q1 		$1K Sell
41
-186
-82% -$4.76K ﹤0.01% 541
2021
Q4 		$6K Buy
+227
New +$6.58K 0.01% 492

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Sageworth Trust Company of South Dakota's MYGN Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 41 shares — an estimated $1K sold.

Sageworth Trust Company of South Dakota first reported a position in MYGN in Q4 2021 and held it in 3 quarters. The position peaked at $6K in Q4 2021. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 41 Myriad Genetics shares in Q3 2022, an estimated $1K.
  • Sageworth Trust Company of South Dakota first reported a position in Myriad Genetics in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Myriad Genetics position peaked at $6K in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.